Renaissance Technologies
HCAT icon

Renaissance Technologies’s Health Catalyst HCAT Stock Holding History

Renaissance Technologies’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$695K Buy
349,266
+132,197
+61% +$191K ﹤0.01% 2475
2026
Q1 		$276K Buy
+217,069
New +$408K ﹤0.01% 2817
2025
Q4 		– Sell
-45,869
Closed -$131K – 3441
2025
Q3 		$131K Buy
+45,869
New +$157K ﹤0.01% 3220
2024
Q3 		– Sell
-14,700
Closed -$93.9K – 3668
2024
Q2 		$93.9K Sell
14,700
-52,200
-78% -$335K ﹤0.01% 3195
2024
Q1 		$504K Sell
66,900
-32,369
-33% -$295K ﹤0.01% 2862
2023
Q4 		$919K Sell
99,269
-60,200
-38% -$492K ﹤0.01% 2462
2023
Q3 		$1.61M Buy
159,469
+4,869
+3% +$58.1K ﹤0.01% 1989
2023
Q2 		$1.93M Sell
154,600
-112,469
-42% -$1.34M ﹤0.01% 2016
2023
Q1 		$3.12M Buy
267,069
+78,707
+42% +$1M ﹤0.01% 1754
2022
Q4 		$2M Buy
188,362
+31,489
+20% +$304K ﹤0.01% 2065
2022
Q3 		$1.52M Buy
156,873
+98,473
+169% +$1.3M ﹤0.01% 2226
2022
Q2 		$846K Sell
58,400
-278,669
-83% -$4.75M ﹤0.01% 2819
2022
Q1 		$8.81M Buy
337,069
+57,700
+21% +$1.64M 0.01% 1204
2021
Q4 		$11.1M Buy
279,369
+79,300
+40% +$3.61M 0.01% 1018
2021
Q3 		$10M Buy
200,069
+52,000
+35% +$2.84M 0.01% 1037
2021
Q2 		$8.22M Sell
148,069
-9,408
-6% -$501K 0.01% 1318
2021
Q1 		$7.37M Buy
+157,477
New +$7.63M 0.01% 1395

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
CF
CDC Financial Chicago, Illinois $239M AUM
PVM
Palogic Value Management Dallas, Texas $304M AUM 15.15% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Renaissance Technologies's HCAT Position: Q2 2026 in Review

Renaissance Technologies increased its Health Catalyst (HCAT) stake by 61% in Q2 2026, buying an estimated $191K and bringing the position to 349,266 shares worth $695K. The position accounts for ﹤0.01% of the portfolio, ranked #2475.

Renaissance Technologies first reported a position in HCAT in Q1 2021 and has held it in 17 quarters since. The position peaked at $11.1M in Q4 2021. 127 funds tracked by Wall St. Rank hold HCAT as of Q2 2026.

  • Renaissance Technologies held 349,266 shares of Health Catalyst worth $695K as of Q2 2026.
  • Renaissance Technologies bought 132,197 Health Catalyst shares in Q2 2026, an estimated $191K.
  • Health Catalyst made up ﹤0.01% of Renaissance Technologies's portfolio in Q2 2026, its #2475 holding.
  • Renaissance Technologies first reported a position in Health Catalyst in Q1 2021 and has held it in 17 quarters since.
  • Renaissance Technologies's Health Catalyst position peaked at $11.1M in Q4 2021.
  • 127 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.